GRAIL (NASDAQ:GRAL) CFO Sells $322,860.00 in Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CFO Aaron Freidin sold 3,000 shares of the stock in a transaction on Monday, November 16th. The shares were sold at an average price of $107.62, for a total value of $322,860.00. Following the sale, the chief financial officer directly owned 222,364 shares in the company, valued at $23,930,813.68. This trade represents a 1.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Aaron Freidin also recently made the following trade(s):

  • On Monday, October 5th, Aaron Freidin sold 23,619 shares of GRAIL stock. The stock was sold at an average price of $146.39, for a total value of $3,457,585.41.
  • On Monday, September 21st, Aaron Freidin sold 4,100 shares of GRAIL stock. The stock was sold at an average price of $93.34, for a total value of $382,694.00.
  • On Thursday, August 27th, Aaron Freidin sold 7,900 shares of GRAIL stock. The stock was sold at an average price of $85.01, for a total value of $671,579.00.

GRAIL Stock Performance




GRAL opened at $105.60 on Tuesday. The stock has a market capitalization of $4.75 billion, a P/E ratio of -11.12 and a beta of 2.86. The company's 50-day simple moving average is $121.96 and its two-hundred day simple moving average is $79.74. GRAIL, Inc. has a 52-week low of $41.50 and a 52-week high of $166.48.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported ($2.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.45) by $0.24. GRAIL had a negative net margin of 243.80% and a negative return on equity of 16.13%. The firm had revenue of $37.53 million for the quarter, compared to the consensus estimate of $44.21 million. Research analysts forecast that GRAIL, Inc. will post -9.11 EPS for the current fiscal year.

Wall Street Analyst Weigh In

GRAL has been the topic of several research reports. TD Cowen raised their target price on shares of GRAIL from $88.00 to $180.00 and gave the stock a "buy" rating in a report on Tuesday, October 13th. Guggenheim lifted their target price on shares of GRAIL from $75.00 to $155.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Canaccord Genuity Group boosted their target price on shares of GRAIL from $80.00 to $150.00 and gave the company a "buy" rating in a research note on Monday, September 28th. UBS Group boosted their target price on shares of GRAIL from $105.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, October 2nd. Finally, Royal Bank Of Canada increased their price target on GRAIL from $84.00 to $100.00 and gave the company a "sector perform" rating in a report on Thursday, November 5th. Five analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GRAIL has an average rating of "Hold" and an average price target of $128.80.

Get Our Latest Report on GRAIL

Institutional Investors Weigh In On GRAIL

A number of large investors have recently made changes to their positions in the company. BlackRock Inc. grew its stake in shares of GRAIL by 20.5% during the 2nd quarter. BlackRock Inc. now owns 3,577,075 shares of the company's stock valued at $244,207,000 after purchasing an additional 608,539 shares during the period. State Street Corp lifted its stake in shares of GRAIL by 26.1% in the 2nd quarter. State Street Corp now owns 2,385,514 shares of the company's stock worth $162,859,000 after purchasing an additional 493,621 shares during the period. Primecap Management Co. CA bought a new position in shares of GRAIL in the 2nd quarter worth approximately $148,836,000. Bank of America Corp DE boosted its holdings in shares of GRAIL by 29.0% in the first quarter. Bank of America Corp DE now owns 914,114 shares of the company's stock worth $47,241,000 after buying an additional 205,611 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of GRAIL by 88.5% in the first quarter. Dimensional Fund Advisors LP now owns 408,650 shares of the company's stock worth $21,104,000 after buying an additional 191,857 shares during the last quarter.

About GRAIL

(Get Free Report)

GRAIL, Inc. is a healthcare company developing blood-based tests for the early detection of multiple cancers. Its approach analyzes patterns in cell-free DNA, including DNA methylation signals, to help identify a possible cancer signal and predict its origin in the body. GRAIL's flagship product is Galleri, a multi-cancer early detection test intended for use alongside—not as a replacement for—recommended cancer screening. The company also conducts clinical research to evaluate the test and advance its early-detection technology.

Featured Articles

Insider Buying and Selling by Quarter for GRAIL (NASDAQ:GRAL)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at GRAIL?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for GRAIL and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles